When PD-L1 binds to PD-1, the T cells’ ability to proliferate decreases and their cytotoxic ability diminishes, transforming into “exhausted” T cells, leading to immune evasion of the tumor (66–74) (as shown in Figure 2A). The gene discussed is PDCD1; the disease is neoplasm.